Gequelin LC, Riediger IN, Nakatani SM, Biondo AW, Bonfim CM cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation. 2001;72(6):1012-9. 55. Tsai DE, Douglas L, Andreadis C, Vogl DT, Arnoldi S, Kotloff R, et al. EBV PCR in the diagnosis and monitoring of post-transplant lymphoproliferative disorder: results of a two-arm prospective trial. A J Transplant. 2008;8(5):1016-24. 56. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol. 2000;38 (2):712-5. 57. Aalto SM, Juvonen E, Tarkkanen J, Volin L, Haario H, Ruutu T, et al. Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients. Clin Infect Dis. 2007; 45(10):1305-9. 58. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku S. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma. 2002;43(1):173-9. 59. vanEsser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood. 2001;98(4):972-8. 60. Jabs WJ, Hennig H, Kittel M, Pethig K, Smets F, Bucsky P, et al. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for post-transplant lymphoproliferative disorders. J Clin Microbiol. 2001;39(2):564-9. 61. Stevens SJ, Verschuuren EA, Verkuujlen SA, Van Den Brule AJ, Meijer CJ, Middeldorp JM. Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post- transplant lymphoproliferative disease. Leuk Lymphoma. 2002; 43(4):831-40. 62. Lankester AC, van Tol MJ, Vossen JM, Kroes AC, Claas E. Epstein- Barr virus (EBV) DNA quantification in pediatric allogenic stem cell recipients: prediction of EBV-associated lymphoproliferative disease. Blood. 2002;99(7):2630-1. xxx 63. Wagner HJ, Cheng YC, Huls MH, Gee AP, Kuehnle I, Krance RA, et al. Prompt versus preemptive intervention for EBV lympho- proliferative disease. Blood. 2004;103(10):3979-81. 64. Yancoski J, Danielian S, Ibanez J, Turconi A, Cuarterolo M, Zelazko M, et al. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR. J ClinVirol. 2004;31 (1):58-65. 65. Meerbach A, Wutzler P, Hafer R, Zintl F, Gruhn B. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease. J Med Virol. 2008;80(3):441-54. 66. Schubert S, Renner C, Hammer M, AbdulKhaliq H, Lehmkuhl HB, Berger F, et al. Relationship of immunosuppression to Epstein- Barr viral load and lymphoproliferative disease in pediatric heart transplant patients. J Heart Lung Transplant. 2008;27(1):100-5. 67. Fafi-Kremer S, Morand P, Barranger C, Bargues G, Magro S, Bes J, et al. Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms. J MolDiagn. 2008;10(1):78-84. 68. Coppoletta S, Tedone E, Galano B, Soracco M, Raiola AM, Lamparelli T, et al. Rituximab Treatment for Epstein-Barr Virus DNAemia after alternative-donor Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant.2011;17(6): 901-7. 69. Lau AH, Soltys K, Sindhi RK, Bond G, Mazariegos GV, Green M. Chronic high Epstein-Barr viral load carriage in pediatric small bowel transplant recipients. Pediatric Transplant. 2010;14(4): 549-53. 70. Schonberger S, Meisel R, Adams O, Pufal Y, Laws HJ, Enczmann J, et al. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2010;16(10): 1428-35. 71. Lay ML, Lucas RM, Ratnamohan M, Taylor J, Ponsonby AL, Dwyer DE. Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol J. 2010;7:252. 388 Rev Bras Hematol Hemoter. 2011;33(5):383-8